Radiosensitization and DNA repair inhibition by the combined use of novel inhibitors of DNA-dependent protein kinase and poly(ADP-ribose) polymerase-1.
Stephany Veuger(Newcastle University), Barbara W. Durkacz
PubMed
September 15, 2003
Cited by 331
Related Papers
DNA-Dependent Protein Kinase Is a Therapeutic Target and an Indicator of Poor Prognosis in B-Cell Chronic Lymphocytic Leukemia
|Clinical Cancer Research|2008|91
Novel iron chelator SK4 demonstrates cytotoxicity in a range of tumour derived cell lines
|Frontiers in Molecular Biosciences|2022|5